No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Accenture and Intel Support Neuromorphic Research Project to Develop Robotic Arm for Wheelchair-Bound Pediatric Patients

Editor: What To Know

  • “This funding from Accenture, along with additional support from Intel and ABR, is allowing us to explore the implementation of adaptive controls on neuromorphic hardware in an effort to address the need for a collaborative, user-friendly, accurate robotic arm at a significantly reduced cost.
  • Wheelchair users will be able to independently control the robotic arm to perform daily tasks that require strength and dexterity of arms and hands, such as drinking from a glass, with 50% fewer errors and a 48% improvement in energy efficiency over traditional control methods.
  • Researchers from Accenture Labs and Intel Labs are working with researchers from Open University of Israel to build a wheelchair-mounted robotic arm with adaptive controls, using an algorithm developed by Applied Brain Research (ABR) and Intel's neuromorphic computing hardware.

Accenture and Intel are supporting a neuromorphic computing research project led by the Neuro-Biomorphic Engineering Lab (NBEL) at the Open University of Israel in collaboration with ALYN Hospital, Israel’s leading pediatric and adolescent rehabilitation center. Funded by Accenture through its participation in the Intel Neuromorphic Research Community (INRC), the project is focused on developing and testing a wheelchair-mounted robotic arm to assist patients with performing daily tasks.

Researchers from Accenture Labs and Intel Labs are working with researchers from Open University of Israel to build a wheelchair-mounted robotic arm with adaptive controls, using an algorithm developed by Applied Brain Research (ABR) and Intel’s neuromorphic computing hardware. Wheelchair users will be able to independently control the robotic arm to perform daily tasks that require strength and dexterity of arms and hands, such as drinking from a glass, with 50% fewer errors and a 48% improvement in energy efficiency over traditional control methods. The device will undergo clinical testing and evaluation with patients at ALYN Hospital who rely on electric wheelchairs and have motor impairment of their upper extremities.

Studies suggest that wheelchair-mounted robotic arms provide an increased sense of independence for users and that these assistive tools can reduce the need for caregiver time by up to 41 percent. Today, however, the cost of these devices is incredibly high, making them inaccessible to many people who need them.

“The ability of robotic arms to benefit people today is largely limited due to high cost and excessive power consumption,” said Elishai Ezra Tsur, lead project researcher at the Open University of Israel. “This funding from Accenture, along with additional support from Intel and ABR, is allowing us to explore the implementation of adaptive controls on neuromorphic hardware in an effort to address the need for a collaborative, user-friendly, accurate robotic arm at a significantly reduced cost.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

VeraClinic: Pioneering Personal Transformation Through Hair Transplantation and Cosmetic Surgery in Turkey

As a testament to Turkey's legacy in the world of aesthetic medicine, VeraClinic invites you to discover the transformative power of our hair transplantation and cosmetic surgery services.

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy